TENET HEALTHCARE CORP(THC)— Stock Profile, AI Score & Financials
Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
TENET HEALTHCARE CORP (THC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores THC at 66.2/100 on a 32-signal composite quality model, placing it at rank #431 of 2,960 stocks — the top 25% of the AI-ranked universe. THC scores in the top quartile across revenue scale (93.2), balance sheet strength (85.0). Areas of concern include revenue growth (33.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), TENET HEALTHCARE CORP reports quarterly revenue of $5.6B, net income of $1.0B, free cash flow of $417.0M. Top institutional holders of THC by reported 13-F value include BlackRock, PRICE T ROWE ASSOCIATES, Boston Partners, based on the most recent SEC filings. THC trades on the NYSE exchange and files with the SEC under CIK 70318. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate THC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENET HEALTHCARE CORP directly from SEC EDGAR.
AI Quality Score
66.2/100
AI Rank
#431
Revenue
$5.6B
Net Income
$1.0B
Free Cash Flow
$417.0M
THC key financials by period
TENET HEALTHCARE CORP reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$21.3B
$2.4B
16.5%
FY 2024
10-K
$20.7B
$4.1B
28.8%
FY 2023
10-K
$20.6B
$1.3B
12.2%
FY 2022
10-K
$19.2B
$1.0B
12.2%
FY 2021
10-K
$19.5B
$1.5B
14.7%
FY 2020
10-K
$17.6B
—
11.3%
Institutions holding THC
Institutional investors reporting a position in TENET HEALTHCARE CORP on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-07-29 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Tenet's Q2 revenue rose 6.8% YoY to $5.628B, but operating income nearly doubled to $1.501B largely because of a one-time $413M contract-termination payment from the CHI/Conifer settlement.
Biggest Revenue Drivers
Hospital Operations$4,240M+6.0% YoY
Higher patient volumes, partially offset by a less favorable payer mix
Ambulatory Care$1,388M+9.3% YoY
Driven by 2025/2026 acquisitions, de novo development and same-facility commercial rate increases
Biggest Revenue Drivers
Total revenue: $5.628B+6.8% YoY
Hospital Operations$4,240M+6.0% YoY
Higher patient volumes, partially offset by a less favorable payer mix
Within Hospital Operations
Managed care$2,470M+1.9% YoY
Includes Medicare and Medicaid managed care programs
Medicaid$505M+33% YoY
Growth tied to DSH and other supplemental program revenue
Ambulatory Care$1,388M+9.3% YoY
Driven by 2025/2026 acquisitions, de novo development and same-facility commercial rate increases
Largest Expense Items
Salaries, wages and benefits$2,231M+3.3% YoY
Annual merit increases and higher incentive compensation, partly offset by lower health benefits cost
Supplies$984M+5.6% YoY
Higher patient volumes, partially offset by cost-efficiency measures
Other operating expenses, net$1,174M+4.9% YoY
Increases in malpractice expense and medical fees
Margins: Operating margin expanded to 26.7% from 15.6% a year ago, but the filing attributes 7.3 percentage points of revenue to the one-time contract-termination payment, meaning underlying margin improvement is smaller than the headline suggests.
Watch Items from the Filing
$413M of Q2 revenue came from a one-time contract-termination payment tied to the CHI/Conifer Omnibus Agreement, not recurring operations.
Managed care fell to 67.3% of net patient service revenue from 70.2% while Medicaid rose to 13.8% from 11.0%, a less favorable payer mix shift.
OBBBA Medicaid provisions taking effect mostly in 2027 (work requirements, provider tax limits, state-directed payment caps) could materially reduce future Medicaid payments; Tenet cannot yet estimate the impact.
Repurchased 5.675 million shares for $1.042 billion in the quarter, with $2.130 billion still authorized after a $2.0 billion increase in June 2026.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
